Joseph D. Ruether
Arthur J.E. Child Comprehensive Cancer Centre · 70 works · 4,555 citations · h-index 28
Top works
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators
- Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes
- Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.
- C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer
- Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance
- Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience
- Impact of Providing Audiotapes of Primary Adjuvant Treatment Consultations to Women With Breast Cancer: A Multisite, Randomized, Controlled Trial
- Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi‐site, randomized, controlled trial
- Intermittent chemotherapy in patients with metastatic androgen‐independent prostate cancer
- A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer
- High dose calcitriol may reduce thrombosis in cancer patients
- Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role
- Updated results from the enfortumab vedotin phase 1 (EV-101) study in patients with metastatic urothelial cancer (mUC).
- Behind closed doors II: systematic analysis of prostate cancer patients' primary treatment consultations with radiation oncologists and predictors of satisfaction with communication
- Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care
- Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).
- Clinical Experience of the Multimodality Management of Anaplastic Thyroid Cancer and Literature Review
- Belzutifan for Advanced Pheochromocytoma or Paraganglioma
- Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hemopoietic cells.